Healthcare provider profile · identity verified

Timothy Michael Costa, MD

Internal Medicine · FALLON, NV · NPI 1265586093

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	665	207
Lisinopril	Lisinopril	591	189
Amlodipine Besylate	Amlodipine Besylate	554	158
Levothyroxine Sodium	Levothyroxine Sodium	543	160
Metformin Hcl	Metformin Hcl	391	115
Albuterol Sulfate Hfa	Albuterol Sulfate	367	120
Omeprazole	Omeprazole	328	102
Losartan Potassium	Losartan Potassium	297	92
Metoprolol Succinate	Metoprolol Succinate	238	77
Furosemide	Furosemide	226	75
Simvastatin	Simvastatin	210	66
Tamsulosin Hcl	Tamsulosin Hcl	209	67
Hydrochlorothiazide	Hydrochlorothiazide	198	62
Metoprolol Tartrate	Metoprolol Tartrate	166	48
Eliquis	Apixaban	163	49
Allopurinol	Allopurinol	159	44
Glipizide	Glipizide	156	49
Citalopram Hbr	Citalopram Hydrobromide	143	48
Gabapentin	Gabapentin	140	58
Meloxicam	Meloxicam	139	43
Potassium Chloride	Potassium Chloride	130	48
Carvedilol	Carvedilol	125	40
Pantoprazole Sodium	Pantoprazole Sodium	125	42
Rosuvastatin Calcium	Rosuvastatin Calcium	117	40
Lovastatin	Lovastatin	116	36
Trazodone Hcl	Trazodone Hcl	101	31
Clopidogrel	Clopidogrel Bisulfate	100	29
Montelukast Sodium	Montelukast Sodium	96	29
Pravastatin Sodium	Pravastatin Sodium	85	25
Ozempic	Semaglutide	76	19
Fluticasone Propionate	Fluticasone Propionate	70	34
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	70	23
Metformin Hcl Er	Metformin Hcl	70	22
Fluoxetine Hcl	Fluoxetine Hcl	69	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	68	18
Spironolactone	Spironolactone	68	21
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	67	23
Prednisone	Prednisone	65	23
Atenolol	Atenolol	64	21
Jardiance	Empagliflozin	63	16
Finasteride	Finasteride	62	19
Alendronate Sodium	Alendronate Sodium	60	17
Sertraline Hcl	Sertraline Hcl	60	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	58	28
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	53	17
Escitalopram Oxalate	Escitalopram Oxalate	49	17
Triamcinolone Acetonide	Triamcinolone Acetonide	47	20
Warfarin Sodium	Warfarin Sodium	47	17
Ibuprofen	Ibuprofen	46	16
Ventolin Hfa	Albuterol Sulfate	46	15
Glipizide Er	Glipizide	44	14
Hydroxyzine Hcl	Hydroxyzine Hcl	44	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	41	12
Ondansetron Hcl	Ondansetron Hcl	41	suppressed
Januvia	Sitagliptin Phosphate	40	suppressed
Glimepiride	Glimepiride	38	12
Esomeprazole Magnesium	Esomeprazole Magnesium	37	suppressed
Breo Ellipta	Fluticasone/Vilanterol	36	11
Trulicity	Dulaglutide	36	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	35	16
Acyclovir	Acyclovir	34	14
Duloxetine Hcl	Duloxetine Hcl	34	13
Pioglitazone Hcl	Pioglitazone Hcl	34	13
Famotidine	Famotidine	33	15
Benazepril Hcl	Benazepril Hcl	31	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Estradiol	Estradiol	29	suppressed
Xarelto	Rivaroxaban	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Novolog	Insulin Aspart	28	suppressed
Clonidine Hcl	Clonidine Hcl	27	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	21
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	24	suppressed
Naproxen	Naproxen	24	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Humulin N	Insulin Nph Human Isophane	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Irbesartan	Irbesartan	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Amiodarone Hcl	Amiodarone Hcl	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Nystatin	Nystatin	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Topiramate	Topiramate	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Verapamil Er	Verapamil Hcl	20	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Tresiba Flextouch U-200	Insulin Degludec	18	suppressed
Cephalexin	Cephalexin	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Spiriva Respimat	Tiotropium Bromide	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	14
Carbamazepine	Carbamazepine	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Methimazole	Methimazole	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Digoxin	Digoxin	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	12	suppressed
Armour Thyroid	Thyroid,pork	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error